Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
CALCIUM CARBONATE
Takeda UK Limited
A12AA04
CALCIUM CARBONATE
500 Milligram
Tablets Chewable
Product not subject to medical prescription
Calcium
Transfer Pending
2014-01-06
PATIENT INFORMATION LEAFLET CALCICHEW* 500 MG CHEWABLE TABLETS calcium carbonate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must talk to a you do not feel better or if you feel worse after two weeks. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Calcichew 500 mg is and what it is used for 2. What you need to know before you take Calcichew 500 mg 3. How to take Calcichew 500 mg 4. Possible side-effects 5. How to store Calcichew 500 mg 6. Contents of the pack and other information 1. WHAT CALCICHEW 500 MG IS AND WHAT IT IS USED FOR Calcichew 500 mg Chewable Tablets are orange flavoured chewable tablets containing the active ingredient calcium. Calcium is found in the diet and is an important substance in bone formation. Calcichew 500 mg is used to treat and prevent calcium deficiency which may occur if your diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or during pregnancy. It may also be given to patients receiving kidney dialysis to remove the phosphate from the blood that cannot be removed by dialysis. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CALCICHEW 500 MG DO NOT TAKE CALCICHEW 500 MG CHEWABLE TABLETS IF YOU: are allergic (hypersensitive) to calcium or any of the other ingredients of this medicine (listed in section 6) have a condition that causes excessive amounts of calcium in your blood or urine (hypercalcaemia or hypercalciuria) have kidney stones. WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR OR PHARMACIST BEFORE TAKING Prečítajte si celý dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Calcichew 500mg Chewable Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains calcium carbonate 1250 mg equivalent to 500mg of elemental calcium. Excipients with known effect: Isomalt (E953) – 62 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Chewable Tablet. Round, white, uncoated and convex tablet. May have small specks. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS To correct calcium deficiency states and maintain appropriate balance in such disorders as osteoporosis, osteomalacia, rickets, tetany, malabsorption states and in pregnancy and lactation. As a phosphate binding agent in the management of renal failure in patients on renal dialysis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY _ADULTS:_ Adjunctive therapy in osteoporosis: 2 to 3 tablets daily. Prevention and treatment of calcium deficiency: 2 to 3 tablets daily. Phosphate binder: Dose as required by the individual patient depending on serum phosphate level. SPECIAL PATIENT POPULATIONS _ELDERLY PATIENTS:_ Dosage as for adults. _PAEDIATRIC PATIENTS:_ Prevention and treatment of calcium deficiency: 2 to 3 tablets daily. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _2_ _/_ _0_ _5_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _2_ _1_ _8_ _7_ _7_ _3_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ Phosphate Binder: Dose as required by the individual patient depending on serum phosph Prečítajte si celý dokument